Search research articles
Contact Us
Filters
Showing results (811-820 of 846) with videos related to
Page
of 85
Sort By:
Science (New York, N.Y.)
|
October 10, 2009
Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome
Vincent C Lombardi, Francis W Ruscetti, Jaydip Das Gupta, et al.
Circulation
|
February 21, 2002
Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis
Lynne E Nield, Earl D Silverman, Glenn P Taylor, et al.
The Journal of Biological Chemistry
|
February 13, 2003
RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR
Khalid S A Khabar, Yunus M Siddiqui, Fahad al-Zoghaibi, et al.
Seminars in Oncology
|
February 14, 2002
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
Leo I Gordon, Thomas E Witzig, Greg A Wiseman, et al.
The Journal of Infectious Diseases
|
October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overview
Michael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 22, 2020
A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency
Salima Daou, Manisha Talukdar, Jinle Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2018
<i>IFNL4</i>-ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer
Wei Tang, Tiffany A Wallace, Ming Yi, et al.
European Journal of Nuclear Medicine
|
August 22, 2000
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma
G A Wiseman, C A White, M Stabin, et al.
AJNR. American Journal of Neuroradiology
|
June 6, 2015
Hot Topics in Research: Preventive Neuroradiology in Brain Aging and Cognitive Decline
C A Raji, H Eyre, S H Wei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 18, 2022
H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer
Mehdi Baratchian, Ritika Tiwari, Sirvan Khalighi, et al.
Page
of 85
Search research articles
Search
Showing results (811-820 of 846) with videos related to
Sort By:
Page
of 85
Science (New York, N.Y.)
|
October 10, 2009
Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome
Vincent C Lombardi, Francis W Ruscetti, Jaydip Das Gupta, et al.
Circulation
|
February 21, 2002
Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis
Lynne E Nield, Earl D Silverman, Glenn P Taylor, et al.
The Journal of Biological Chemistry
|
February 13, 2003
RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR
Khalid S A Khabar, Yunus M Siddiqui, Fahad al-Zoghaibi, et al.
Seminars in Oncology
|
February 14, 2002
Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
Leo I Gordon, Thomas E Witzig, Greg A Wiseman, et al.
The Journal of Infectious Diseases
|
October 5, 2010
Determinants of protection among HIV‐exposed seronegative persons: an overview
Michael M Lederman, Galit Alter, Demetre C Daskalakis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 22, 2020
A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency
Salima Daou, Manisha Talukdar, Jinle Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2018
<i>IFNL4</i>-ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer
Wei Tang, Tiffany A Wallace, Ming Yi, et al.
European Journal of Nuclear Medicine
|
August 22, 2000
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma
G A Wiseman, C A White, M Stabin, et al.
AJNR. American Journal of Neuroradiology
|
June 6, 2015
Hot Topics in Research: Preventive Neuroradiology in Brain Aging and Cognitive Decline
C A Raji, H Eyre, S H Wei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 18, 2022
H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer
Mehdi Baratchian, Ritika Tiwari, Sirvan Khalighi, et al.
Page
of 85